Liver Diseases: all 2,094 studies
Page 13 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Efficacy, Safety, and Adequacy of EUS-guided Liver BiopsyCompletedNCT04055870
- Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT04049396Not applicable
- Glucagon Resistance in Patients With NAFLDCompletedNCT04042142Not applicable
- Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver DiseaseCompletedNCT04028869
- Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.CompletedNCT04022941Not applicable
- Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) StudyCompletedNCT04022681
- The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal SurgeryWithdrawnNCT04021264Phase 2/3
- Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.Status unknownNCT04015570Not applicable
- Diabetes, Exercise and Liver Fat (DELIVER)CompletedNCT04004273Not applicable
- A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver DiseaseCompletedNCT03998514Phase 1
- Monocytic Expression of HLA-DR After Liver TransplantationCompletedNCT03995537
- Exercise Study in Subjects With NAFLDCompletedNCT03995056Not applicable
- Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver DiseaseCompletedNCT03986684
- Super HEROES: Searching How the Extract Rebaudioside Occludes Excess SteatosisCompletedNCT03985020Not applicable
- A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic ImpairmentCompletedNCT03983161Phase 1
- Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese AdultsStatus unknownNCT03972631Not applicable
- A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASHStatus unknownNCT03970031Phase 3
- Give a MANNA a Fish, Teach a MANNA to FishWithdrawnNCT03969199Not applicable
- Telehealth Intervention in CirrhoticsCompletedNCT03969186Not applicable
- Risk Factors for Major Complications After Liver ResectionCompletedNCT03967067
- Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic FunctionCompletedNCT03962049Phase 1
- Glycemic Characterization and Pancreatic Imaging Correlates in Cystic FibrosisCompletedNCT03961516
- Automatic Segmentation of Polycystic LiverStatus unknownNCT03960710
- Effects of Red Ginseng on Liver FunctionCompletedNCT03945123Not applicable
- Chia Supplementation and Non Alcoholic Fatty Liver DiseaseCompletedNCT03942822Not applicable
- S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver DiseaseStatus unknownNCT03938662Not applicable
- Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT03936803Not applicable
- Integrated Approaches for Identifying Molecular Targets in Liver DiseaseCompletedNCT03915002
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
- A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT03902002Phase 1
- Patterns and Outcome of Autoimmune Related Liver DiseaseCompletedNCT03898414
- An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver DamageCompletedNCT03890809Phase 1
- Defining 'Normal' Liver Function Tests & FibroScan Values in PregnancyStatus unknownNCT03883789
- NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationTerminatedNCT03866421
- NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction ReversalWithdrawnNCT03864835Not applicable
- The Effect of Curcumin on Liver Fat Content in Obese SubjectsCompletedNCT03864783Not applicable
- Hepatic Histology and Metabolism Following Total Pancreatectomy and PancreaticoduodenectomyStatus unknownNCT03864744
- Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaActive, not recruitingNCT03863730Not applicable
- Feasibility of VIIT in Adults With NASHCompletedNCT03861819Not applicable
- Nicotinamide in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT03850886Phase 2
- Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).Status unknownNCT03848390Not applicable
- Exploring the Comorbidity Between Mental Disorders and General Medical ConditionsCompletedNCT03847753
- Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver DiseaseCompletedNCT03847116
- Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisStatus unknownNCT03842748
- Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver DiseaseCompletedNCT03842254Early Phase 1
- Clinical Trial of New Hypothermic Oxygenated Perfusion System Versus Static Cold StorageStatus unknownNCT03837197Not applicable
- Role of Obeticholic Acid in the Patients of NAFLD With Raised ALTCompletedNCT03836937Not applicable
- Postprandial Lipotoxicity and Nonalcoholic Fatty Liver DiseaseCompletedNCT03836443Not applicable
- Monitoring the HePAtological TOXicity of Drugs (HePATOX)CompletedNCT03833297
- A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched VolunteersCompletedNCT03832426Phase 1
- NAFLD Among Patients With Type 2 Diabetes and CKDCompletedNCT03826381
- Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy SubjectsCompletedNCT03824678Phase 1
- NASH and Coronary DiseaseStatus unknownNCT03819283Not applicable
- A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentCompletedNCT03816631Phase 1
- Contrast Enhanced Ultrasound Guidance Biopsy for the Diagnosis of Liver TumorsStatus unknownNCT03811431Not applicable
- Repeatability and Reproducibility of Quantitative MRCPCompletedNCT03809559
- Role of Ajwa Derived Polyphenols in DyslipidaemiasStatus unknownNCT03805139Not applicable
- Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic SteatohepatitisStatus unknownNCT03803540Phase 1
- Pharmacokinetics of Imeglimin in Hepatic Impaired SubjectsCompletedNCT03802786Phase 1
- Validation of Point of Care Liver Function TestsTerminatedNCT03800069
- A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic FunctionCompletedNCT03799848Phase 1
- Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver DiseaseCompletedNCT03796975Phase 4
- COMPARISON OF LIVER RETRACTOR FOR INTRATOPERATIVE LIVER DAMAGECompletedNCT03795844Not applicable
- Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver DiseaseCompletedNCT03791203Not applicable
- Population-based Study in Screening for Liver FibrosisCompletedNCT03789825
- Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityStatus unknownNCT03787108
- Time Restricted Feeding on Nonalcoholic Fatty Liver DiseaseCompletedNCT03786523Not applicable
- Ketogenic Diet in Non-alcoholic Fatty Liver DiseaseCompletedNCT03784716Not applicable
- Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.CompletedNCT03778411
- A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound ViscoelasticityStatus unknownNCT03777293Not applicable
- Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to EliminationStatus unknownNCT03776760
- Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled TrialCompletedNCT03774511Not applicable
- Enhanced Recovery After Surgery for Hepatobiliary-Pancreatic SurgeryCompletedNCT03772392
- School-Based Program On Metabolic DiseaseCompletedNCT03768245Not applicable
- International Liver Surgery Outcomes StudyCompletedNCT03768141
- A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver DiseaseTerminatedNCT03767829Phase 1/2
- Accuracy of the LiverVision® Semi-automated Liver Volumetry SoftwareStatus unknownNCT03766633
- Elafibranor Pharmacokinetic Parameters in Hepatic Impaired PatientsCompletedNCT03765671Phase 1
- Evaluation of the Sarcopenia in Hepatobiliary SurgeryTerminatedNCT03754452
- Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER TrialStatus unknownNCT03749070Not applicable
- Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver DiseaseTerminatedNCT03748511
- Repeatability and Reproducibility of Multiparametric MRICompletedNCT03743272
- A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy SubjectsCompletedNCT03742882Phase 1
- Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver DiseaseCompletedNCT03738358Not applicable
- The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled StudyStatus unknownNCT03734510Not applicable
- Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant SurvivalCompletedNCT03723317
- A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic ImpairmentCompletedNCT03713242Phase 1
- Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral DrugsCompletedNCT03706898Phase 1
- Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as ReferenceCompletedNCT03704792Not applicable
- Liver Health and Metabolic Function in People With ObesityCompletedNCT03701828Not applicable
- Comparative Trial of Home-Based Palliative CareTerminatedNCT03694431Not applicable
- An Observational Study of Patients With Chronic Hepatitis B (CHB) InfectionTerminatedNCT03692897
- De Novo Lipogenesis in Severity of NAFLDCompletedNCT03683589
- Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control SubjectsCompletedNCT03681457Phase 1
- Effects of Exercise on VLDL-TG MetabolismCompletedNCT03678727
- Technical Validation of MR Biomarkers of Obesity-Associated NAFLDCompletedNCT03674528
- An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney FunctionCompletedNCT03674476Phase 1
- Liver Function After Intravenous Methylprednisolone AdministrationCompletedNCT03667157Phase 4
- ObeSity Related Colorectal Adenoma RiskCompletedNCT03663062
- Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03648086Not applicable